
Asembia 2025: GLP-1 Drugs Reshape Reimbursement and Coverage Models
In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current and future state of the market. The conversation highlighted the rapid growth of specialty …